FutureMeds Appoints IT leader, Grzegorz Krówczyński as Vice President of IT
Updated: Jan 24
FutureMeds has appointed Grzegorz Krówczyński as Vice President of IT. He will be responsible for designing, developing and implementing organisational information systems, software applications, and the IT infrastructure of FutureMeds’ growing dedicated research site network.
With over 17 years of professional experience and deep domain knowledge of Business Intelligence, Data Management and Clinical Trial Management Systems, Grzegorz will play a key role in building FutureMeds' IT arm and ensuring that the company is fully prepared and ready for driving innovations in Clinical Trials market.
“Grzegorz joining FutureMeds is pivotal for the company’s growth in transforming clinical trials market. I’m excited to see how his in-depth understanding of life science sector will benefit our clients and transform clinical trials into fully digitalised process.”
- Marcin Gondek CFO at FutureMeds
A graduate of the Politechnika Wrocławska with a master’s degree in Computer Science & Management, Grzegorz has worked in the life sciences sector since 2014 where he held various leadership roles in Digital & IT. Most recently, he motivated and led multiple teams as the Director of Global Site Technologies at one of the leading SMOs.
Throughout the last 8 years, Grzegorz worked on decentralized trials in over 10 countries. He managed data migration with a new Clinical Trial Management system and a global Robotic Process Automation solution which drove process improvements that increased company performance. He also led the Business Intelligence, Data Management, Data Science, and Global Site Technologies teams. As FutureMeds keeps growing, Grzegorz’s leadership experience will be a tremendous asset for FutureMeds.
As part of the FutureMeds executive team, he will work to define and implement the IT solutions strategy to support the development, digitalization and leadership of FutureMeds across Europe.
Commenting on his FutureMeds’s vision, Grzegorz commented - “I aim to transform FutureMeds into a fully digitised professional company using the latest IT technologies on the market. Working with the Digital and IT team, we will support the company's development and ensure security for our patients, clients and organisation.”
FutureMeds is a fast-growing independent Site Management Organisation and operates 12 sites across 4 countries. The independent SMO is already in the top tier of Dedicated Research Site Networks in Europe and its’ Dedicated Research Sites across the continent are currently involved in running clinical trials on behalf of its clients in pharma and CROs.
FutureMeds is a fast-growing independent Dedicated Research Site Network supporting pharmaceutical companies, Sponsors and CROs and contributing to research to find effective treatments and medications for all patients who need them.
FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help accelerate patient access to new treatments.
Through acquisitions and a strategic focus on patient experience, FutureMeds has developed qualified patient pools across Europe that enables faster patient enrollment and strong retention and help generate more accurate results.
Follow us on LinkedIn
Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.